Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference
Key Highlights
- ➤Wave CEO Paul Bolno to join Chardan RNA therapeutics panel October 20
- ➤Panel webcast scheduled for 9:45 a.m. ET in New York City
- ➤Wave pipeline includes obesity, alpha-1 antitrypsin deficiency and liver disease programs
Expert Statements
Paul Bolno, President and Chief Executive Officer of Wave Life Sciences
“Reimagine Possible”
CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in the “RNA Medicines: Next-Generation RNA Therapeutics” panel at Chardan’s 10(th) Annual Healthcare Conference in New York City on Tuesday, October 20, 2026 at 9:45 a.m. ET.
A live webcast of the panel can be accessed by visiting “Investor Events” on the Investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. A replay of this panel will be archived and available on the site for a limited time following the event.
Get started
Create a free account to read the full story.